Rainer H. Böger

Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction

Rainer H. Böger, Stefanie M. Bode‐Böger, Andrzej Szuba et al. · Circulation · 1998 · 1.2K citations · Full text

Medicine, Cardiology, Pharmacology +12

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

Carmine Zoccali, Stefanie M. Bode‐Böger, Francesca Mallamaci et al. · The Lancet · 2001 · 1.1K citations

Medicine, Nephrology, Pharmacology +8

Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone)

Joseph V. Pergolizzi, Rainer H. Böger, Keith Budd et al. · Pain Practice · 2008 · 859 citations

Medicine, Pharmacology, Pharmacotherapy +17

Pharmacokinetic and pharmacodynamic properties of oral L‐citrulline and L‐arginine: impact on nitric oxide metabolism

Edzard Schwedhelm, Renke Maas, Ralf Freese et al. · British Journal of Clinical Pharmacology · 2007 · 501 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Biochemical Evidence for Impaired Nitric Oxide Synthesis in Patients With Peripheral Arterial Occlusive Disease

Rainer H. Böger, Stefanie M. Bode‐Böger, W Thiele et al. · Circulation · 1997 · 492 citations

Medicine, Cardiology, Pharmacology +12